Syngen Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 06, 2019 at 01:21 pm EST
Share
Syngen Biotech Co., Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 347.908 million compared to TWD 309.564 million a year ago. Operating income was TWD 61.221 million compared to TWD 57.420 million a year ago. Net income was TWD 45.427 million compared to TWD 47.950 million a year ago. Basic earnings per share was TWD 1.97 compared to TWD 2.08 a year ago. Diluted earnings per share was TWD 1.97 compared to TWD 2.07 a year ago. For the nine months, sales was TWD 966.261 million compared to TWD 766.132 million a year ago. Operating income was TWD 177.722 million compared to TWD 115.149 million a year ago. Net income was TWD 137.963 million compared to TWD 90.623 million a year ago. Basic earnings per share was TWD 5.97 compared to TWD 3.92 a year ago.
Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Companyâs products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.
SYNGEN BIOTECH CO.,LTD. 
